SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-022831
Filing Date
2020-05-07
Accepted
2020-05-07 16:06:09
Documents
3
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mirm-8k_20200507.htm 8-K 33569
2 EX-99.1 mirm-ex991_6.htm EX-99.1 127499
3 GRAPHIC gjk2quqay2an000001.jpg GRAPHIC 7901
  Complete submission text file 0001564590-20-022831.txt   173221
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 20856304
SIC: 2834 Pharmaceutical Preparations